¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Cell, stem"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
cylindrical cell
¿øÁÖ¼¼Æ÷
cytotoxic cell
¼¼Æ÷µ¶¼º¼¼Æ÷
cytotoxic cell protein
¼¼Æ÷µ¶¼º¼¼Æ÷´Ü¹éÁú
cytotoxic killer T cell
¼¼Æ÷µ¶¼º»ìÇØT¼¼Æ÷
cell
¼¼Æ÷
cell adhesion molecule
¼¼Æ÷ºÎÂøºÐÀÚ
cell agar plate
¼¼Æ÷¿ì¹«ÆòÆÇ
cell bank
¼¼Æ÷ÀºÇà
cell body
¼¼Æ÷ü
cell color ratio
ÀûÇ÷±¸»ö¼Òºñ
cell culture
¼¼Æ÷¹è¾ç
cell cycle
¼¼Æ÷ÁÖ±â
cell death
¼¼Æ÷»ç
cell dedifferentiation
¼¼Æ÷Å»ºÐÈ
cell division
¼¼Æ÷ºÐ¿
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
cell lethality
¼¼Æ÷Ä¡»çÀ²
cell line
¼¼Æ÷°è, ¼¼Æ÷ÁÖ
cell loss
¼¼Æ÷¼Ò½Ç
cell mass
¼¼Æ÷µ¢ÀÌ
cell membrane
¼¼Æ÷¸·
cell organelle
¼¼Æ÷¼Ò±â°ü
cell respiration
¼¼Æ÷È£Èí
cell strain
¼¼Æ÷ÁÖ
cell substitution
¼¼Æ÷´ëÄ¡, Ç÷±¸´ëÄ¡
cell swelling
¼¼Æ÷Á¾Ã¢
cell adhesion molecule
¼¼Æ÷ºÎÂøºÐÀÚ
cell agar plate
¼¼Æ÷¿ì¹«ÆòÆÇ
cell color ratio
ÀûÇ÷±¸»ö¼Òºñ
cell labeling technique
¼¼Æ÷Ç¥Áö±â¹ý
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
T cell immunity
T¼¼Æ÷¸é¿ª
T cell leukemia
T¼¼Æ÷(¹éÇ÷º´
T cell lymphoma
T¼¼Æ÷¸²ÇÁÁ¾
T cell receptor
T¼¼Æ÷[Ç׿ø]¼ö¿ëü
T cell receptor gene
T¼¼Æ÷[Ç׿ø]¼ö¿ëü À¯ÀüÀÚ
T cell replacing factor
T¼¼Æ÷ ´ëüÀÎÀÚ
T cell/lymphocyte
T ¼¼Æ÷/¸²ÇÁ±¸
T-cell
T-¼¼Æ÷
T-cell differentiation
T-¼¼Æ÷ºÐÈ
T-cell growth factor
T-¼¼Æ÷¼ºÀåÀÎÀÚ
Th cell
Th¼¼Æ÷, Á¶·ÂT¼¼Æ÷, º¸Á¶T¼¼Æ÷
Ts cell
¾ïÁ¦T¼¼Æ÷
Tzanck cell
Á¤Å© ¼¼Æ÷
abnormality of cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
accessory cell
º¸Á¶¼¼Æ÷, ºÎ¼ö¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
adenoid basal cell carcinoma
¼±»ó(àÍßÒ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adenoid squamous cell carcinoma
¼±»ó ÆíÆò »óÇǼ¼Æ÷(àÍßÒ ø·øÁ ß¾ù«á¬øà) ¾Ï
adult T Cell leukemia virus
¼ºÀÎ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
adult T cell leukemia virus (HTLV)
¼ºÀÎT¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
adult t-cell leukemia/lymphoma
¼º¼÷ T-¼¼Æ÷ ¹éÇ÷º´/¸²ÇÁÁ¾(à÷âÙ¡á¬øà ÛÜúìÜ»/¡ðþ)
aggressive basal cell carcinoma
ħ½À ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell tumor
¾ËÆÄ ¼¼Æ÷Á¾(¡á¬øàðþ)
amacrine cell
¾Æ¸¶Å©¸° ¼¼Æ÷
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
analyzer for cell count
¼¼Æ÷¼öºÐ¼®±â
aneuploid cell
À̼ö¼º¼¼Æ÷
angiotropic (intravascular) large cell lymphoma
Ç÷°ü¿µ¾ç¼º(Ç÷°ü³»)´ë¼¼Æ÷¸²ÇÁÁ¾
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½